Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$107912.0.

  • Selectis Health's Net Cash Flow rose 9509.65% to -$107912.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$598585.0, marking a year-over-year increase of 5206.65%. This contributed to the annual value of -$912757.0 for FY2024, which is 71585.76% down from last year.
  • Per Selectis Health's latest filing, its Net Cash Flow stood at -$107912.0 for Q3 2025, which was up 9509.65% from -$693775.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Net Cash Flow ranged from a high of $2.0 million in Q2 2024 and a low of -$2.2 million during Q3 2024
  • In the last 5 years, Selectis Health's Net Cash Flow had a median value of -$216857.0 in 2023 and averaged -$144962.7.
  • Data for Selectis Health's Net Cash Flow shows a peak YoY increase of 75830.55% (in 2022) and a maximum YoY decrease of 146234.04% (in 2022) over the last 5 years.
  • Selectis Health's Net Cash Flow (Quarter) stood at $1.2 million in 2021, then tumbled by 129.13% to -$343559.0 in 2022, then tumbled by 123.15% to -$766656.0 in 2023, then skyrocketed by 43.83% to -$430630.0 in 2024, then soared by 74.94% to -$107912.0 in 2025.
  • Its last three reported values are -$107912.0 in Q3 2025, -$693775.0 for Q2 2025, and $633732.0 during Q1 2025.